chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Specific gravity urine normal, Ultrasound abdomen normal, Ultrasound antenatal screen normal
Clinical narrative: Patient awoke with severe headache.  Progressed to abdominal pain which was band like across entire abdomen.  Patient presented to labor and delivery with severe hypertension and tachycardia---168/110 and hr 138. Fetal heart rate also tachycardic on presentation in the 180's.  Temp 99.4. Pain was treated with nubain and IV fluids.  Full work up for Cholecystitis, appendicitis, preterm labor, preeclampsia were all performed and were all normal.  After 12 hours of treatment with pain meds and IV fluids patient is at this time feeling better. Blood pressure and heart rate (both maternal and fetal) have returned to normal.  Pain was rated at 8/10 but is now 2/10. Patient remains with localized erythema and swelling at injection site on right arm.
Age: 33.0
Sex: F
Vaccine: FLUN4
Symptoms: Axillary pain, Erythema, Swelling, Tenderness
Clinical narrative: Redness, swelling, 95mm by 60mm.  Patient denies nausea/vomiting/diarrhea.  Tender, pain in armpit.
Age: 18.0
Sex: F
Vaccine: FLUN4, MNQ
Symptoms: Blister, Nasal disorder
Clinical narrative: Client states she had blister like bump inside of nose. No bump visable when examinded by RN.
Age: 30.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain, Malaise, Myalgia, Pyrexia
Clinical narrative: Mild fever, malaise, myalgias lasting more than 16 hours, mostly responding to antipyretic medication (alternately taking acetaminophen and ibuprofen). Also tenderness and soreness with movement at the injection site (like most vaccinations).
Age: 6.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site irritation, Injection site pruritus, Rash macular
Clinical narrative: Pts arm shows blotchy redness with flare, No wheals noticed "elevation." Pt stated the site was itchy/irritating as well.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Oral discomfort, Rash
Clinical narrative: Mouth burning, rash on arms and upper torso. Pt. used Benadryl per her Dr. and seems to be getting better.
Age: 16.0
Sex: F
Vaccine: FLUX
Symptoms: Dizziness
Clinical narrative: Feeling faint. Had to sit down. Dizzy.
Age: 71.0
Sex: F
Vaccine: FLU3
Symptoms: Body temperature increased, Injection site discolouration, Injection site erythema, Injection site swelling
Clinical narrative: Point of turned blue increase to size of $.50 area around turned red  and continued towards elbow with swelling and temperature increase over period of 3 hours. Condition somewhat same last 48 hours.
Age: 0.56
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Chest X-ray normal, Cough, Laboratory test abnormal, Pertussis, Polymerase chain reaction
Clinical narrative: This is one case out of a cumulative total of 235 cases solicited from the EDSS database during the surveillance period from 01 January 2010 to 23 September 2014. These 235 cases represent children who received 3 or more doses of Sanofi Pasteur vaccine; cases of pertussis disease in children who received DTaP combination vaccines from other manufacturers are not reported as per study protocol. Initial report was received on 23 September 2014 from the Investigator participating in a post-marketing study under the reference number M5A16. A case of pertussis disease in a 14 month-old male subject (initials not collected) was identified by the investigator based on review of data from the Electronic Disease Surveillance (EDSS) electronic database. The subject had received three doses of PENTACEL; dose one on 23 August 2013 (lot number C4478AB), dose two on 01 November 2013 (C4478AB) and dose three on 17 January 2014 (lot number C4577AA) (routes and sites of administration for all doses not reported). Approximately 225 days after the last dose, on 30 August 2014, the subject developed a cough. Five days later, on 04 September 2014, the subject developed a paroxysmal cough. The subject also experienced post-tussive vomiting and sleep disturbance on an unspecified date. Laboratory testing included a positive PCR on 08 September 2014. Chest x-ray findings were negative for pneumonia. Corrective treatments consisted of Azithromycin starting on 09 September 2014 for five days. The subject was not hospitalized. At the time of final contact on 15 September 2014, the subject's cough was still persisting. The duration of the cough was reported at that time as 16 days. Investigator causality assessment is not required as per protocol. Documents held by sender: None.
Age: 0.56
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Post-tussive vomiting, Sleep disorder
Clinical narrative: This is one case out of a cumulative total of 235 cases solicited from the EDSS database during the surveillance period from 01 January 2010 to 23 September 2014. These 235 cases represent children who received 3 or more doses of Sanofi Pasteur vaccine; cases of pertussis disease in children who received DTaP combination vaccines from other manufacturers are not reported as per study protocol. Initial report was received on 23 September 2014 from the Investigator participating in a post-marketing study under the reference number M5A16. A case of pertussis disease in a 14 month-old male subject (initials not collected) was identified by the investigator based on review of data from the Electronic Disease Surveillance (EDSS) electronic database. The subject had received three doses of PENTACEL; dose one on 23 August 2013 (lot number C4478AB), dose two on 01 November 2013 (C4478AB) and dose three on 17 January 2014 (lot number C4577AA) (routes and sites of administration for all doses not reported). Approximately 225 days after the last dose, on 30 August 2014, the subject developed a cough. Five days later, on 04 September 2014, the subject developed a paroxysmal cough. The subject also experienced post-tussive vomiting and sleep disturbance on an unspecified date. Laboratory testing included a positive PCR on 08 September 2014. Chest x-ray findings were negative for pneumonia. Corrective treatments consisted of Azithromycin starting on 09 September 2014 for five days. The subject was not hospitalized. At the time of final contact on 15 September 2014, the subject's cough was still persisting. The duration of the cough was reported at that time as 16 days. Investigator causality assessment is not required as per protocol. Documents held by sender: None.
Age: 32.0
Sex: F
Vaccine: FLUX
Symptoms: Activities of daily living impaired, Exposure during pregnancy, Headache, Pain in extremity
Clinical narrative: Sore arm started the evening before (9/25/2014) at about 8:00 PM, in the morning when I got up, I had a pounding headache. Had to leave work early due to headache.
Age: 72.0
Sex: F
Vaccine: FLU3
Symptoms: Headache, Injection site bruising, Rash
Clinical narrative: Patient had bruising on arm where she received the vaccine starting within a day of vaccination. She developed a bilateral leg rash that lasted for approximately a week that was accompanied with occasional headaches.
Age: 55.0
Sex: F
Vaccine: FLUX
Symptoms: Chills, Oropharyngeal pain, Pain, Pyrexia
Clinical narrative: Chills, sore throat, fever, aches.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Erythema, Swelling
Clinical narrative: Pt reports swelling/redness that has been getting worse since.
Age: 45.0
Sex: F
Vaccine: FLU3
Symptoms: Feeling abnormal, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: "Don't feel right", red, warm, swollen at injection site.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site swelling
Clinical narrative: Increased redness, increased swelling, induration to injection site.  Area tender to touch.  No fever.
Age: 31.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site induration, Injection site pain, Injection site warmth
Clinical narrative: 1.5 inch in diameter induration at injection site.  Injection site warm to touch and painful.
Age: 34.0
Sex: M
Vaccine: FLU4
Symptoms: Dysphonia, Ocular hyperaemia, Rhinorrhoea, Throat irritation
Clinical narrative: Itchy throat, nunny nose, hoarse voice, very reddened sclera.
Age: 76.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Polymerase chain reaction, Varicella virus test positive
Clinical narrative: Typical varicella zoster rash - left T7-8 distribution.  Positive VZ PCR from blister fluid.  Treated with Valtrex.
Age: 32.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Headache, Injection site erythema, Injection site pain, Pain, Pyrexia
Clinical narrative: Injection site soreness, bodyaches later day of injection. Fever up to 104, 09/24 and 102.5 09/25. Bodyaches, headache. Erythema measures 11 cm x 8 cm around injection site.
Age: 18.0
Sex: M
Vaccine: HPV4, MNQ
Symptoms: Confusional state, Dyskinesia, Injection site discomfort, Loss of consciousness, Muscle rigidity
Clinical narrative: Client age 18 received Menactra vaccine #2 and HPV4 vaccine #1 today. At approximately 9:25 am, client was given injections. Immediately prior to injections, client stated that he has "passed out" with shots before when he was younger. Following the injections, RN assessed client's status, client was alert and responsive indicating that he felt fine and "it only feels weird right here" pointing to the area of injection and stated that he had not eaten yet today. RN obtained juice for client and before he could begin drinking it client became pale, slumped against the wall and lost consciousness for approximately 15 seconds accompanied by seizure-like movements that lasted approximately 10 seconds. Client was not responsive, his eyes were open but not focused, his body became rigid and his arms tightened up with slow uncontrolled movements. Client was seated throughout the episode. Following the episode the client became responsive stating "yes" when asked if he was ok, however appeared to be confused. Approximately 5 seconds later client stated "ok, now I remember where I am" and normal skin color returned. Throughout the episode, RN provided supportive care ensuring client safety. EMS was not called as client was fully recovered from the episode within 1 minute. Client drank 2 juice boxes and remained seated with RN monitoring for approximately 15 minutes and then moved to the waiting room, where he remained for an additional 15 minutes or RN monitoring. Client did not experience any additional side effects. Client states, he plans to continue the vaccine series, and was instructed to return in 2 months, and to be sure to have a full breakfast with natural sugars and juice prior to vaccinations. Based on my assessment and client statement, he was fully recovered, and left the clinic after approximately 30 minutes.
Age: 18.0
Sex: M
Vaccine: HPV4, MNQ
Symptoms: Pallor, Posture abnormal, Seizure like phenomena, Unresponsive to stimuli, Vision blurred
Clinical narrative: Client age 18 received Menactra vaccine #2 and HPV4 vaccine #1 today. At approximately 9:25 am, client was given injections. Immediately prior to injections, client stated that he has "passed out" with shots before when he was younger. Following the injections, RN assessed client's status, client was alert and responsive indicating that he felt fine and "it only feels weird right here" pointing to the area of injection and stated that he had not eaten yet today. RN obtained juice for client and before he could begin drinking it client became pale, slumped against the wall and lost consciousness for approximately 15 seconds accompanied by seizure-like movements that lasted approximately 10 seconds. Client was not responsive, his eyes were open but not focused, his body became rigid and his arms tightened up with slow uncontrolled movements. Client was seated throughout the episode. Following the episode the client became responsive stating "yes" when asked if he was ok, however appeared to be confused. Approximately 5 seconds later client stated "ok, now I remember where I am" and normal skin color returned. Throughout the episode, RN provided supportive care ensuring client safety. EMS was not called as client was fully recovered from the episode within 1 minute. Client drank 2 juice boxes and remained seated with RN monitoring for approximately 15 minutes and then moved to the waiting room, where he remained for an additional 15 minutes or RN monitoring. Client did not experience any additional side effects. Client states, he plans to continue the vaccine series, and was instructed to return in 2 months, and to be sure to have a full breakfast with natural sugars and juice prior to vaccinations. Based on my assessment and client statement, he was fully recovered, and left the clinic after approximately 30 minutes.
Age: 70.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site swelling
Clinical narrative: Moderate/major swelling from shoulder to elbow (right) from PNEUMOVAX 23. Pt contacted her MD.
Age: 37.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: 3 cm area of erythema and induration at site of injection 20 hr post injection.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Nausea, Pyrexia
Clinical narrative: Woke up on 9/25/14 in the morning was very lightheaded, dizzy and nauseated. Patient called to report at 9:07 am. As day progressed was feeling better but ran low grade fever 99.8. 9/26/14 - 8:30 woke up again feeling dizzy/nauseated. Will continue to monitor.
Age: 66.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Pain, Pain in extremity, Pruritus, Pyrexia
Clinical narrative: Aching. Starting to develop low grade fever. Itching that resolved itself w/in 24 hours. Pain in left arm.
Age: 45.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Chills, Injection site reaction, Rash macular
Clinical narrative: Patient's husband reported that pat experienced chills and had a series of red blotches around the site where the injection occurred. Symptoms occurred approx 24 hrs after vaccine.
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Adverse event, Blood test, Herpes zoster, Laboratory test, Nuclear magnetic resonance imaging
Clinical narrative: Information has been received from a currently 67 year old male consumer reporting on himself with drug hypersensitivity to ROCEPHIN who in March 2010, was vaccinated with a dose of ZOSTAVAX (Merck) (lot number, dose and route not reported). Concomitant therapy included PREVACID, CYMBALTA and gabapentin. The consumer reported that soon after having the vaccine administered on an unspecified date (in 2010) he developed shingles. The patient mentioned he had it on both sides of the face and that it kept reoccurring. The patient also mentioned that he developed Bell's palsy because of the shingles. The patient sought unspecified medical attention and VALTREX was given as treatment. Blood tests and a Magnetic Resonance Imaging test (MRI) were performed (results not provided). At the time of the report the patient's outcome for Bell's palsy was unknown. Follow up information was received concerning a 67 year old female patient regarding herself. Patient's current condition included drug allergy with ROCEPHIN (manufacturer unknown). On an unknown date (previously reported as March 2010) patient was vaccinated with ZOSTAVAX dose, route, lot number unknown. On an unknown date patient experienced reoccurrences of shingles three to five times a year, every year and also had Bell's palsy since receiving ZOSTAVAX. On an unknown date patient was hospitalized for an unknown event in an unspecified hospital for 3 days and was treated with antiviral medications (name, dose, frequency and manufacturer unknown). On an unknown date unspecified labs and diagnostic were performed. Patient also reported that he received Acyclovir (dose, frequency and manufacturer unknown) as a treatment for shingles and as long as he used the treatment the outbreak of shingles was not reoccurring. Outcome of the shingles was recovered. Outcome of all other events were unknown. Causality of the events was unknown. Additional information has been requested.
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: VIIth nerve paralysis
Clinical narrative: Information has been received from a currently 67 year old male consumer reporting on himself with drug hypersensitivity to ROCEPHIN who in March 2010, was vaccinated with a dose of ZOSTAVAX (Merck) (lot number, dose and route not reported). Concomitant therapy included PREVACID, CYMBALTA and gabapentin. The consumer reported that soon after having the vaccine administered on an unspecified date (in 2010) he developed shingles. The patient mentioned he had it on both sides of the face and that it kept reoccurring. The patient also mentioned that he developed Bell's palsy because of the shingles. The patient sought unspecified medical attention and VALTREX was given as treatment. Blood tests and a Magnetic Resonance Imaging test (MRI) were performed (results not provided). At the time of the report the patient's outcome for Bell's palsy was unknown. Follow up information was received concerning a 67 year old female patient regarding herself. Patient's current condition included drug allergy with ROCEPHIN (manufacturer unknown). On an unknown date (previously reported as March 2010) patient was vaccinated with ZOSTAVAX dose, route, lot number unknown. On an unknown date patient experienced reoccurrences of shingles three to five times a year, every year and also had Bell's palsy since receiving ZOSTAVAX. On an unknown date patient was hospitalized for an unknown event in an unspecified hospital for 3 days and was treated with antiviral medications (name, dose, frequency and manufacturer unknown). On an unknown date unspecified labs and diagnostic were performed. Patient also reported that he received Acyclovir (dose, frequency and manufacturer unknown) as a treatment for shingles and as long as he used the treatment the outbreak of shingles was not reoccurring. Outcome of the shingles was recovered. Outcome of all other events were unknown. Causality of the events was unknown. Additional information has been requested.
Age: 25.0
Sex: F
Vaccine: FLU4
Symptoms: Erythema, Feeling hot, Injection site induration, Pain, Pruritus
Clinical narrative: Redness and soreness on 9/22/14. Awoke on 9/23/14 was hot, swollen, and little itchy. Showed nurses 9/23/14 afternoon. Put ice pack to site and soaked in bath 9/23/14 evening. On 9/24/14, redness decreased and more itchy. Nurse measured 93mm hard induration at injection site on 9/23/14 at 14:40.
Age: 25.0
Sex: F
Vaccine: FLU4
Symptoms: Swelling
Clinical narrative: Redness and soreness on 9/22/14. Awoke on 9/23/14 was hot, swollen, and little itchy. Showed nurses 9/23/14 afternoon. Put ice pack to site and soaked in bath 9/23/14 evening. On 9/24/14, redness decreased and more itchy. Nurse measured 93mm hard induration at injection site on 9/23/14 at 14:40.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Feeling hot, Injection site erythema, Injection site warmth, Wheezing
Clinical narrative: Dr reports wheezing in the 1st 24 hrs which improved also reddened 3 x 3 lower than injection site viewed 9/25/14 as well as warm to touch and generalized warmth.
Age: 54.0
Sex: F
Vaccine: FLUN4
Symptoms: Skin warm
Clinical narrative: Pt noticed hot at nare that occurred after FLUMIST and increased in the 2-3 days following intranal flu immunization.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Rash.
Age: 37.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site pain, Neck pain
Clinical narrative: The flu was administered at a school site. The patient reported to the school nurse on 9/18/14 that he had severe pain in his right arm going into his shoulder and neck ever since the injection. The nurse reported this information to me on 9/19/14 and that she advised him to see his physician. I contacted him on 9/22/14. He had not seen a doctor but the pain was not improved.
Age: 53.0
Sex: F
Vaccine: FLUX
Symptoms: Headache, Injection site bruising, Malaise, Pain
Clinical narrative: Headache, diffuse aching, general malaise; 3" x 3" bruise at injection site.
Age: 51.0
Sex: F
Vaccine: FLU3
Symptoms: Activities of daily living impaired, Autoinflammatory disease, Back pain, Insomnia, Intervertebral disc degeneration
Clinical narrative: Clinician forced needle below deltoid muscle. I DON'T RECALL EXACT TIME. MY 2 KIDS WERE WITH ME. I REMEMBER THINKING IT SHOULDN'T HAVE TO BE FORCED WHEN INJECTED. (I AM A NURSE). BUT AFTER THAT I DIDN'T GIVE IT MUCH THOUGHT UNTIL MY ARM DISCOMFORT/PAIN WAS STILL PRESENT 3 MOS AFTER. I WAS ALSO BEGINNING TO EXPERIENCE WIDE-SPREAD BODY ACHES, MOSTLY AT NIGHT, BUT THEY ARE BAD ENOUGH THAT I HAVE DIFFICULTY SLEEPING AND NEED TO TAKE MEDICATION. I SAY A BACK SPECIALIST BECAUSE MY BACK AND NECK STARTED TO HURT AT THE SAME TIME AS THE BODY ACHES STARTED. WAS TOLD I HAD PROGRESSIVE DEGENERATIVE DISK DISEASE WHICH WAS THE FIRST I EVER ENCOUNTER ANY BACK DISCOMFORT. ORTHOPEDIST COULDN'T EXPLAIN THE THROBBING WIDESPREAD BODY ACHES. I THEN SAW A RHEUMATOLOGIST WHO DX THE "AUTOIMMUNE INFLAMMATORY PROCESS". I HAVE NOT BEEN ABLE TO RETURN TO MY PREINJECTION WORKOUT PROGRAM; I EXPERIENCE CONSTANT THROBBING ACHES/PAINS -MOSTLY AT NIGHT. EXERCISE EXACERBATES IT. TO SEE RHEUMATOLOGIST FOR FOLLOW-UP ON OCTOBER 6.
Age: 51.0
Sex: F
Vaccine: FLU3
Symptoms: Limb discomfort, Musculoskeletal discomfort, Neck pain, Nuclear magnetic resonance imaging abnormal, Pain
Clinical narrative: Clinician forced needle below deltoid muscle. I DON'T RECALL EXACT TIME. MY 2 KIDS WERE WITH ME. I REMEMBER THINKING IT SHOULDN'T HAVE TO BE FORCED WHEN INJECTED. (I AM A NURSE). BUT AFTER THAT I DIDN'T GIVE IT MUCH THOUGHT UNTIL MY ARM DISCOMFORT/PAIN WAS STILL PRESENT 3 MOS AFTER. I WAS ALSO BEGINNING TO EXPERIENCE WIDE-SPREAD BODY ACHES, MOSTLY AT NIGHT, BUT THEY ARE BAD ENOUGH THAT I HAVE DIFFICULTY SLEEPING AND NEED TO TAKE MEDICATION. I SAY A BACK SPECIALIST BECAUSE MY BACK AND NECK STARTED TO HURT AT THE SAME TIME AS THE BODY ACHES STARTED. WAS TOLD I HAD PROGRESSIVE DEGENERATIVE DISK DISEASE WHICH WAS THE FIRST I EVER ENCOUNTER ANY BACK DISCOMFORT. ORTHOPEDIST COULDN'T EXPLAIN THE THROBBING WIDESPREAD BODY ACHES. I THEN SAW A RHEUMATOLOGIST WHO DX THE "AUTOIMMUNE INFLAMMATORY PROCESS". I HAVE NOT BEEN ABLE TO RETURN TO MY PREINJECTION WORKOUT PROGRAM; I EXPERIENCE CONSTANT THROBBING ACHES/PAINS -MOSTLY AT NIGHT. EXERCISE EXACERBATES IT. TO SEE RHEUMATOLOGIST FOR FOLLOW-UP ON OCTOBER 6.
Age: 51.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity, Wrong technique in drug usage process, X-ray abnormal
Clinical narrative: Clinician forced needle below deltoid muscle. I DON'T RECALL EXACT TIME. MY 2 KIDS WERE WITH ME. I REMEMBER THINKING IT SHOULDN'T HAVE TO BE FORCED WHEN INJECTED. (I AM A NURSE). BUT AFTER THAT I DIDN'T GIVE IT MUCH THOUGHT UNTIL MY ARM DISCOMFORT/PAIN WAS STILL PRESENT 3 MOS AFTER. I WAS ALSO BEGINNING TO EXPERIENCE WIDE-SPREAD BODY ACHES, MOSTLY AT NIGHT, BUT THEY ARE BAD ENOUGH THAT I HAVE DIFFICULTY SLEEPING AND NEED TO TAKE MEDICATION. I SAY A BACK SPECIALIST BECAUSE MY BACK AND NECK STARTED TO HURT AT THE SAME TIME AS THE BODY ACHES STARTED. WAS TOLD I HAD PROGRESSIVE DEGENERATIVE DISK DISEASE WHICH WAS THE FIRST I EVER ENCOUNTER ANY BACK DISCOMFORT. ORTHOPEDIST COULDN'T EXPLAIN THE THROBBING WIDESPREAD BODY ACHES. I THEN SAW A RHEUMATOLOGIST WHO DX THE "AUTOIMMUNE INFLAMMATORY PROCESS". I HAVE NOT BEEN ABLE TO RETURN TO MY PREINJECTION WORKOUT PROGRAM; I EXPERIENCE CONSTANT THROBBING ACHES/PAINS -MOSTLY AT NIGHT. EXERCISE EXACERBATES IT. TO SEE RHEUMATOLOGIST FOR FOLLOW-UP ON OCTOBER 6.
Age: 13.0
Sex: M
Vaccine: FLUN4, HPV4
Symptoms: Dyspnoea, Nasal congestion, Rhinalgia
Clinical narrative: Client complains his nose hurts, his nose is stuffy and hard to breathe through nose.
Age: 11.0
Sex: M
Vaccine: FLU3, HPV4, MNQ, TDAP
Symptoms: Injection site erythema, Injection site swelling, Pain
Clinical narrative: Erythema, swelling of left deltoid to elbow, on 09/25/14, c/o pain on 09/26/2014.
Age: 21.0
Sex: F
Vaccine: MMR
Symptoms: Rash pruritic
Clinical narrative: Developed itchy rash.
Age: 53.0
Sex: M
Vaccine: FLU3
Symptoms: Middle insomnia, Pruritus, Urticaria
Clinical narrative: WOKE UP DUE TO ITCHING, HAD HIVES ON ARMS AND LEGS. NO TROUBLE BREATHING. DID NOT TAKE ANY MEDICATION. WENT BACK TO SLEEP AND HIVES AND ITCHING GONE WHEN AWOKE. HAD NOT TAKEN ANY NEW MEDICINES, EATEN ANY NEW FOODS AND NO NEW SOAPS OR DETERGENT.
Age: 11.0
Sex: F
Vaccine: HPV4
Symptoms: Abdominal pain upper, Activities of daily living impaired, Bradycardia, Grand mal convulsion, Hypotension
Clinical narrative: This spontaneous report as received from a consumer also reporter as a private investigator refers to an 11 year old female patient (also reported as 15 year old female). Pertinent medical history, drug reactions or allergies were not reported. On an unknown date, at the age of 11 years old, the patient was vaccinated with GARDASIL (dose, dose number, dose schedule, route, anatomical location, lot number and expiration date were not reported). No concomitant therapies were reported. On an unknown date, 15 minutes after receiving the GARDASIL, the patient experienced grand mal seizure at the unspecified physician's office. On unspecified dates, the patient experienced stomach pain, low blood pressure, syncope with episodes of bradycardia and paralysis. The patient also had missed school on unspecified dates for 18 months as a result of these adverse events. Laboratory diagnostic studies were not reported. The reported stated that the receiving GARDASIL, nearly cost patient's life. The outcome of the events was reported as not recovered. The relatedness between the events and GARDASIL was not reported. Grand mal seizure, stomach pain, low blood pressure, syncope with episodes of bradycardia and paralysis were considered to be life threatening and disabling by the reporter. Upon internal review, grand mal seizure and paralysis were considered to be medically significant. Additional information is not expected because the reporter refused additional contact.
Age: 11.0
Sex: F
Vaccine: HPV4
Symptoms: Paralysis, Syncope
Clinical narrative: This spontaneous report as received from a consumer also reporter as a private investigator refers to an 11 year old female patient (also reported as 15 year old female). Pertinent medical history, drug reactions or allergies were not reported. On an unknown date, at the age of 11 years old, the patient was vaccinated with GARDASIL (dose, dose number, dose schedule, route, anatomical location, lot number and expiration date were not reported). No concomitant therapies were reported. On an unknown date, 15 minutes after receiving the GARDASIL, the patient experienced grand mal seizure at the unspecified physician's office. On unspecified dates, the patient experienced stomach pain, low blood pressure, syncope with episodes of bradycardia and paralysis. The patient also had missed school on unspecified dates for 18 months as a result of these adverse events. Laboratory diagnostic studies were not reported. The reported stated that the receiving GARDASIL, nearly cost patient's life. The outcome of the events was reported as not recovered. The relatedness between the events and GARDASIL was not reported. Grand mal seizure, stomach pain, low blood pressure, syncope with episodes of bradycardia and paralysis were considered to be life threatening and disabling by the reporter. Upon internal review, grand mal seizure and paralysis were considered to be medically significant. Additional information is not expected because the reporter refused additional contact.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Axillary pain, Blood electrolytes normal, Cellulitis, Full blood count, Local swelling
Clinical narrative: This spontaneous report was received from a registered nurse and refers to a 66 year old female patient. Concurrent conditions include asthma, former smoker and penicillin allergy. The patient's medical history included congestive heart failure and migraines. On 18-SEP-2014 the patient was vaccinated with a dose of PNEUMOVAX 23 (dose unknown) lot # J004387, expiry: 04-JAN-2015, intramuscular in the right deltoid. Concomitant therapies included IMITREX, NEURONTIN and other unspecified medication. On 18-SEP-2014, on the same evening the patient experienced right axillary pain. On 19-SEP-2014 the patient sought medical attention to a local emergency department and was hospitalized the same day for right arm swelling/cellulitis. The laboratory tests revealed white blood count normal as 5.8 (units not specified), electrolytes normal, CBC blood work labs results not reported and patient did not have fever. The patient was under observation and was treated with vancomycin (manufacturer unknown) intravenously (IV). The nurse stated it was unknown when the patient was released from the hospital (approximately in September 2014). The outcome of right arm swelling/cellulitis was unknown. The causality was unknown. The reporter considered the event right arm swelling/cellulitis to be medically significant. Additional information is not expected.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: White blood cell count normal
Clinical narrative: This spontaneous report was received from a registered nurse and refers to a 66 year old female patient. Concurrent conditions include asthma, former smoker and penicillin allergy. The patient's medical history included congestive heart failure and migraines. On 18-SEP-2014 the patient was vaccinated with a dose of PNEUMOVAX 23 (dose unknown) lot # J004387, expiry: 04-JAN-2015, intramuscular in the right deltoid. Concomitant therapies included IMITREX, NEURONTIN and other unspecified medication. On 18-SEP-2014, on the same evening the patient experienced right axillary pain. On 19-SEP-2014 the patient sought medical attention to a local emergency department and was hospitalized the same day for right arm swelling/cellulitis. The laboratory tests revealed white blood count normal as 5.8 (units not specified), electrolytes normal, CBC blood work labs results not reported and patient did not have fever. The patient was under observation and was treated with vancomycin (manufacturer unknown) intravenously (IV). The nurse stated it was unknown when the patient was released from the hospital (approximately in September 2014). The outcome of right arm swelling/cellulitis was unknown. The causality was unknown. The reporter considered the event right arm swelling/cellulitis to be medically significant. Additional information is not expected.
Age: 38.0
Sex: F
Vaccine: FLUX
Symptoms: Arthralgia, Immediate post-injection reaction, Injected limb mobility decreased, Joint stiffness, Pain
Clinical narrative: 1) Received flu shot on left arm. 2) Localized pain was immediate. Pain was not consistent with prior flu shot administrations. 3) At approx. 5:40 PM on the day of the shot, I began to have a throbbing pain in the area surrounding the joint and severe pain & stiffness in the joint itself. 4) The morning of 09/25/14, my left arm was in severe pain, along with stiffness and the inability to move my left arm to any appreciable degree. 5) As of 09/26/14, the pain and lack of motion in my left arm has not subsided and is the same as it was on 09/25/14.
Age: 38.0
Sex: F
Vaccine: FLUX
Symptoms: Pain in extremity
Clinical narrative: 1) Received flu shot on left arm. 2) Localized pain was immediate. Pain was not consistent with prior flu shot administrations. 3) At approx. 5:40 PM on the day of the shot, I began to have a throbbing pain in the area surrounding the joint and severe pain & stiffness in the joint itself. 4) The morning of 09/25/14, my left arm was in severe pain, along with stiffness and the inability to move my left arm to any appreciable degree. 5) As of 09/26/14, the pain and lack of motion in my left arm has not subsided and is the same as it was on 09/25/14.
Age: 81.0
Sex: M
Vaccine: FLU3
Symptoms: Joint range of motion decreased, Pain, Swelling
Clinical narrative: Patient experienced pain and significant swelling starting within 24 hours of receiving vaccine. Swelling improved, within two days, but pain has remained and range of motion is compromised after 4 days.
Age: 51.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: WHEN GETTING UNDRESS NOTICED LT UPPER ARM RED, TENDER AND WARM TO TOUCH. NO TREATMENT NEEDED.
Age: 52.0
Sex: F
Vaccine: FLU3
Symptoms: Myalgia, Pain in extremity
Clinical narrative: Soreness and muscle pain in left arm.
Age: 28.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain, Injection site pruritus, Injection site reaction, Skin exfoliation
Clinical narrative: Dime size area surrounding injection site in which skin peeled off with burning and itching.
Age: 14.0
Sex: F
Vaccine: TDAP
Symptoms: Activities of daily living impaired, Feeling hot, Injection site discolouration, Rash, Scab
Clinical narrative: Felt "hot" then noticed rash on right arm, then R arm. Started out as a small "whelp" then started peeling, scabbed over around 9-23-14? Self treatment with neosporin. Pt came into H. Dept on 9-24-14 due to nurse at school sent child home due to rash. I noted 2 spots on right arm and 3 spots on left arm. Scabbed over. One spot on right arm was healed, but discolored the skin in area of injection. After discussion with Program Manager advised patient and mother to go see MD. Called patient mother today. She stated, took child to ER. MD stated per mother related to the TDAP injection. Continue with neosporin. Child back in school.
Age: 14.0
Sex: F
Vaccine: TDAP
Symptoms: Skin exfoliation, Urticaria
Clinical narrative: Felt "hot" then noticed rash on right arm, then R arm. Started out as a small "whelp" then started peeling, scabbed over around 9-23-14? Self treatment with neosporin. Pt came into H. Dept on 9-24-14 due to nurse at school sent child home due to rash. I noted 2 spots on right arm and 3 spots on left arm. Scabbed over. One spot on right arm was healed, but discolored the skin in area of injection. After discussion with Program Manager advised patient and mother to go see MD. Called patient mother today. She stated, took child to ER. MD stated per mother related to the TDAP injection. Continue with neosporin. Child back in school.
Age: 10.0
Sex: M
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pain, Pyrexia
Clinical narrative: Where the shot was given: Pain, redness, swelling and fever 100.8. He also has body aches, painful to raise his arm.  Treatment so far: New appointment at facility and ice on arm.
Age: 64.0
Sex: F
Vaccine: FLU3, PPV, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Pt recieved an appropriately spaced Pneumovax 23 sub-q and Zostavax sub-q both in the left tricep area and a IM Fluvirin. The next day the pt experienced a 2x4in oval red mark seemingly between the sites of pneumo and zoster injections with clearly defined margins and complains of itchiness and pain on palpitation. Pt used topical Benadryl on 9/25/2014 with no relief. Suggested to the patient that topical hydrocortisone would be a better option for the itching and redness. Didn't mention any pain relief options to pt because I was concerned if possible systemic effects arose and I wanted to avoid fever suppression.
Age: 55.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Arthralgia, Chills, Oedema mouth, Oropharyngeal pain, Swelling face
Clinical narrative: Sore throat, chills, joint aches swollen face and mouth (tongue), hives in mouth.
Age: 55.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Swollen tongue, Urticaria
Clinical narrative: Sore throat, chills, joint aches swollen face and mouth (tongue), hives in mouth.
Age: 55.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Arthralgia, Chills, Lip swelling, Oral disorder, Oral pain
Clinical narrative: Sore throat, chills, joint aches swollen face and mouth (tongue), hives in mouth.
Age: 55.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Pyrexia, Swelling, Swelling face, Swollen tongue
Clinical narrative: Sore throat, chills, joint aches swollen face and mouth (tongue), hives in mouth.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, HEPA, MMRV
Symptoms: Injection site erythema, Injection site swelling, Pruritus
Clinical narrative: Swelling and redness left lateral thigh first witnessed by parent in morning of 09/20/2014, exacerbating throughout day. Mother took patient to ER 09/20/2014 evening.  Patient was prescribed: Pharmacy: Orapred 15 mg/5 mL oral liquid (Prescribe): 5 mL, Oral, BID, 50 mL hydrOXYzine hydrochloride 10 mg/5 mL oral syrup (Prescribe): 10 mg, 5 mL, Oral, TID, 75 mL, PRN, for itching Septra 200 mg-40 mg/5 mL oral susp (dose on trimethoprim) (Prescribe): 7.5 mL, Oral, BID, 105 mL.
Age: 61.0
Sex: M
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age, No adverse event
Clinical narrative: Adverse Events denied.
Age: 71.0
Sex: F
Vaccine: FLU4
Symptoms: Unevaluable event
Clinical narrative: N/a
Age: 5.0
Sex: F
Vaccine: FLU4
Symptoms: Rash, Urticaria
Clinical narrative: Rash, hive like bumps, on right side of the trunk under ribs, progressing to left side over the day and round to the back resolved with application of hydrocrtisone cream.
Age: 4.0
Sex: M
Vaccine: DTAP, FLU3, IPV, MMRV
Symptoms: Injection site reaction, Injection site swelling, Rash erythematous
Clinical narrative: Erythematous rash on lateral aspect of upper arm with swelling where vaccines were administered.
Age: 37.0
Sex: M
Vaccine: FLU3
Symptoms: Activities of daily living impaired, Dizziness postural, Fatigue, Musculoskeletal pain, Musculoskeletal stiffness
Clinical narrative: General aches and fatigue, most intense around neck and high on shoulders, with stiffness, severe dizziness with change of head position up or down from neutral.  Woke with symptoms, they worsened slightly over 24 hours, faded over next 24 hours, (missed work on 2nd day,) by 3rd day only general fatigue and faint achiness remained.  After 72 hours no symptoms remain except minor, localized tight spots at neck and shoulder "trigger points."
Age: 37.0
Sex: M
Vaccine: FLU3
Symptoms: Neck pain, Pain
Clinical narrative: General aches and fatigue, most intense around neck and high on shoulders, with stiffness, severe dizziness with change of head position up or down from neutral.  Woke with symptoms, they worsened slightly over 24 hours, faded over next 24 hours, (missed work on 2nd day,) by 3rd day only general fatigue and faint achiness remained.  After 72 hours no symptoms remain except minor, localized tight spots at neck and shoulder "trigger points."
Age: 8.0
Sex: F
Vaccine: IPV, TDAP
Symptoms: Rash
Clinical narrative: Rashes, localized at first, then noted to be "spreading".
Age: 10.0
Sex: M
Vaccine: FLUN4
Symptoms: Asthma, Chest X-ray normal, Condition aggravated, Viral test negative
Clinical narrative: SEVERE ASTHMA EXACERBATION.
Age: 50.0
Sex: F
Vaccine: FLUX, VARZOS
Symptoms: Headache, Injection site induration, Injection site nodule, Injection site rash, Injection site swelling
Clinical narrative: Headache within 30 minutes of rec. vaccine.  Swelling in arm and hard knot with rash and heat in the area of injection noticed the next day.
Age: 50.0
Sex: F
Vaccine: FLUX, VARZOS
Symptoms: Injection site warmth
Clinical narrative: Headache within 30 minutes of rec. vaccine.  Swelling in arm and hard knot with rash and heat in the area of injection noticed the next day.
Age: 31.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: S:  received pneumococcal-PS injection yesterday.  No previous Pneumovax that I can find in our records and she does not get immunizations at other locations. That evening noted swelling, warmth and redness around the injection site and it has progressed markedly no dyspnea/wheezing. O:  Marked induration, warmth and mild erythema - 15x25 cm right arm. CTA; RRR; no other skin abnl.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Neck pain, Pain in extremity
Clinical narrative: Left Arm/Neck Pain.
Age: 28.0
Sex: M
Vaccine: FLU3, HEPAB, TDAP, TYP
Symptoms: Dizziness, Loss of consciousness, Syncope
Clinical narrative: Patient fainted while standing at check out desk in hall of office approximately 15 minutes after vaccine.  Stated "I'm feeling dizzy" right before he fainted.  MA was able to help patient as he fell preventing him from hitting his head.  He regained consciousness immediately, and we moved him to a venipuncture chair and had him lie down.  We gave him water and some crackers and put a cool rag on his forehead.  As he began feeling better he sat up and denied any further dizziness or lightheadedness.  He denies pain or discomfort anywhere.  Vital signs after incident  At 1330 were blood pressure 90/58, and pulse 48.  Vital signs 15 minutes later at 1345 were: blood pressure 102/62, and pulse 60.
Age: 18.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: 2 in x 2.5 in swelling at injection site, pain, itch.  Returned to clinic on 9/26, seen by Dr. Prescribed hydrocortisone cream and antihistamine.
Age: 27.0
Sex: F
Vaccine: HEP
Symptoms: Erythema, Local swelling, Pain in extremity, Skin warm
Clinical narrative: Worker stated that left arm started swelling and hurting last night 9/25/14 inform nurse staff this evening on 9/26/14 4 inch in size warm to touch very red in color.
Age: 68.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Red, swollen upper arm area in vicinity of injection site.
Age: 68.0
Sex: F
Vaccine: TYP, YF, TYP, YF
Symptoms: Abdominal pain, Diarrhoea, Dyspnoea, Endotracheal intubation, Hypotension
Clinical narrative: Pt c/o n/v/d, abd pain approximately 3-4 days after recieving the yellow fever and typhoid vacciniations. On 9/5/14 She saw her primary care doctor and was found to be hypotensive with SBP in the 70's. Pt was given 3 liters NS and became short of breath. Sent to ER and found to be thromocytopenic with PLT count of 90. At 0530 on 9/26 pt was found to be unresponsive with agonal respirations and a thready pulse a code blue was called. Patient was intubated, given 1 dose of Epi and transfered to critical care.
Age: 68.0
Sex: F
Vaccine: TYP, YF, TYP, YF
Symptoms: Intensive care, Nausea, Platelet count decreased, Pulse abnormal, Respiration abnormal
Clinical narrative: Pt c/o n/v/d, abd pain approximately 3-4 days after recieving the yellow fever and typhoid vacciniations. On 9/5/14 She saw her primary care doctor and was found to be hypotensive with SBP in the 70's. Pt was given 3 liters NS and became short of breath. Sent to ER and found to be thromocytopenic with PLT count of 90. At 0530 on 9/26 pt was found to be unresponsive with agonal respirations and a thready pulse a code blue was called. Patient was intubated, given 1 dose of Epi and transfered to critical care.
Age: 68.0
Sex: F
Vaccine: TYP, YF, TYP, YF
Symptoms: Thrombocytopenia, Unresponsive to stimuli, Vomiting
Clinical narrative: Pt c/o n/v/d, abd pain approximately 3-4 days after recieving the yellow fever and typhoid vacciniations. On 9/5/14 She saw her primary care doctor and was found to be hypotensive with SBP in the 70's. Pt was given 3 liters NS and became short of breath. Sent to ER and found to be thromocytopenic with PLT count of 90. At 0530 on 9/26 pt was found to be unresponsive with agonal respirations and a thready pulse a code blue was called. Patient was intubated, given 1 dose of Epi and transfered to critical care.
Age: 68.0
Sex: F
Vaccine: TYP, YF, TYP, YF
Symptoms: Cough, Diarrhoea, Endotracheal intubation, Hypotension, Intensive care
Clinical narrative: Pt c/o n/v/d, abd pain approximately 3-4 days after recieving the yellow fever and typhoid vacciniations. On 9/5/14 She saw her primary care doctor and was found to be hypotensive with SBP in the 70's. Pt was given 3 liters NS and became short of breath. Sent to ER and found to be thromocytopenic with PLT count of 90. At 0530 on 9/26 pt was found to be unresponsive with agonal respirations and a thready pulse a code blue was called. Patient was intubated, given 1 dose of Epi and transfered to critical care.
Age: 68.0
Sex: F
Vaccine: TYP, YF, TYP, YF
Symptoms: Malaise, Nausea, Pyrexia, Thrombocytopenia, Unresponsive to stimuli
Clinical narrative: Pt c/o n/v/d, abd pain approximately 3-4 days after recieving the yellow fever and typhoid vacciniations. On 9/5/14 She saw her primary care doctor and was found to be hypotensive with SBP in the 70's. Pt was given 3 liters NS and became short of breath. Sent to ER and found to be thromocytopenic with PLT count of 90. At 0530 on 9/26 pt was found to be unresponsive with agonal respirations and a thready pulse a code blue was called. Patient was intubated, given 1 dose of Epi and transfered to critical care.
Age: 68.0
Sex: F
Vaccine: TYP, YF, TYP, YF
Symptoms: Abdominal pain, Diarrhoea, Dyspnoea, Endotracheal intubation, Hypotension
Clinical narrative: Developed fever, cough and not feeling well 9/21/14 per call from husband on 9/25/14.  Advised to make appt. with doctor.  On 9/26/14 call received for MC nurse that patient was admitted to hospital 9/25/14 with nausea, diarrhea, hypotension and thrombocytopenia. She is intubated in ICU.  She coded at 5 AM 9/26/14 and is now unresponsive.
Age: 68.0
Sex: F
Vaccine: TYP, YF, TYP, YF
Symptoms: Intensive care, Nausea, Platelet count decreased, Pulse abnormal, Respiration abnormal
Clinical narrative: Developed fever, cough and not feeling well 9/21/14 per call from husband on 9/25/14.  Advised to make appt. with doctor.  On 9/26/14 call received for MC nurse that patient was admitted to hospital 9/25/14 with nausea, diarrhea, hypotension and thrombocytopenia. She is intubated in ICU.  She coded at 5 AM 9/26/14 and is now unresponsive.
Age: 68.0
Sex: F
Vaccine: TYP, YF, TYP, YF
Symptoms: Thrombocytopenia, Unresponsive to stimuli, Vomiting
Clinical narrative: Developed fever, cough and not feeling well 9/21/14 per call from husband on 9/25/14.  Advised to make appt. with doctor.  On 9/26/14 call received for MC nurse that patient was admitted to hospital 9/25/14 with nausea, diarrhea, hypotension and thrombocytopenia. She is intubated in ICU.  She coded at 5 AM 9/26/14 and is now unresponsive.
Age: 68.0
Sex: F
Vaccine: TYP, YF, TYP, YF
Symptoms: Cough, Diarrhoea, Endotracheal intubation, Hypotension, Intensive care
Clinical narrative: Developed fever, cough and not feeling well 9/21/14 per call from husband on 9/25/14.  Advised to make appt. with doctor.  On 9/26/14 call received for MC nurse that patient was admitted to hospital 9/25/14 with nausea, diarrhea, hypotension and thrombocytopenia. She is intubated in ICU.  She coded at 5 AM 9/26/14 and is now unresponsive.
Age: 68.0
Sex: F
Vaccine: TYP, YF, TYP, YF
Symptoms: Malaise, Nausea, Pyrexia, Thrombocytopenia, Unresponsive to stimuli
Clinical narrative: Developed fever, cough and not feeling well 9/21/14 per call from husband on 9/25/14.  Advised to make appt. with doctor.  On 9/26/14 call received for MC nurse that patient was admitted to hospital 9/25/14 with nausea, diarrhea, hypotension and thrombocytopenia. She is intubated in ICU.  She coded at 5 AM 9/26/14 and is now unresponsive.
Age: 61.0
Sex: F
Vaccine: FLUX, VARZOS
Symptoms: Body temperature increased, Headache, Influenza like illness, Injection site erythema, Injection site pain
Clinical narrative: Flu like symptoms, severe headache, swelling of injection site.  4' diameter red, warm to touch, raised, very sore injection site.  Temp of 99.3 beginning at 6:00PM on 9/23/2014.  Swelling and redness continued to worsen.  Saw my physician on 9/25/2014.  Headache better by 9/25/2014.  Swelling still at injection site on 9/26/2014, but not as bad.  Itching as of 9/25/2014. Photos available if needed.
Age: 61.0
Sex: F
Vaccine: FLUX, VARZOS
Symptoms: Injection site swelling, Injection site warmth, Pruritus
Clinical narrative: Flu like symptoms, severe headache, swelling of injection site.  4' diameter red, warm to touch, raised, very sore injection site.  Temp of 99.3 beginning at 6:00PM on 9/23/2014.  Swelling and redness continued to worsen.  Saw my physician on 9/25/2014.  Headache better by 9/25/2014.  Swelling still at injection site on 9/26/2014, but not as bad.  Itching as of 9/25/2014. Photos available if needed.
Age: 0.61
Sex: F
Vaccine: FLU3, PNC13
Symptoms: Febrile convulsion, Laboratory test normal, Loss of consciousness
Clinical narrative: Febrile seizure, loss of consciousness.